Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Reduced Activity of GGPPS Mutant is Involved in Bisphosphonates-Induced Atypical Fractures

Michal Lisnyansky, Noa Kapelushnik, Ariel Ben-Bassat, Milit Marom, Anat Loewenstein, Daniel Khananshvili, Moshe Giladi and Yoni Haitin
Molecular Pharmacology October 1, 2018, mol.118.113670; DOI: https://doi.org/10.1124/mol.118.113670
Michal Lisnyansky
1 Tel Aviv University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noa Kapelushnik
1 Tel Aviv University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ariel Ben-Bassat
1 Tel Aviv University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milit Marom
1 Tel Aviv University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anat Loewenstein
2 Tel Aviv University and Tel Aviv Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Khananshvili
1 Tel Aviv University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moshe Giladi
1 Tel Aviv University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoni Haitin
1 Tel Aviv University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

mol.118.113670
DOI 
https://doi.org/10.1124/mol.118.113670
PubMed 
30275041

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online October 1, 2018.

Article Versions

  • You are currently viewing an Earlier version of this article (October 1, 2018 - 05:26).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Michal Lisnyansky1,
  2. Noa Kapelushnik1,
  3. Ariel Ben-Bassat1,
  4. Milit Marom1,
  5. Anat Loewenstein2,
  6. Daniel Khananshvili1,
  7. Moshe Giladi1,*, and
  8. Yoni Haitin1,*
  1. 1 Tel Aviv University;
  2. 2 Tel Aviv University and Tel Aviv Medical Center
  1. ↵*Address correspondence to: yhaitin{at}post.tau.ac.il, moshegil{at}post.tau.ac.il

Statistics from Altmetric.com

Article usage

Article usage: October 2018 to January 2021

AbstractFullPdf
Oct 201842610109
Nov 20183032545
Dec 20181263027
Jan 201955918
Feb 20194368
Mar 20193669
Apr 201922613
May 20194536
Jun 201937517
Jul 201957312
Aug 201968320
Sep 201935113
Oct 201929212
Nov 201962324
Dec 201993317
Jan 2020131810
Feb 202042321
Mar 202052319
Apr 202021918
May 20208189
Jun 202031815
Jul 2020122818
Aug 202011920
Sep 202082422
Oct 202041520
Nov 202021926
Dec 2020101720
Jan 202121425

Next
Back to top

In this issue

Molecular Pharmacology: 99 (2)
Molecular Pharmacology
Vol. 99, Issue 2
1 Feb 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reduced Activity of GGPPS Mutant is Involved in Bisphosphonates-Induced Atypical Fractures
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Reduced Activity of GGPPS Mutant is Involved in Bisphosphonates-Induced Atypical Fractures

Michal Lisnyansky, Noa Kapelushnik, Ariel Ben-Bassat, Milit Marom, Anat Loewenstein, Daniel Khananshvili, Moshe Giladi and Yoni Haitin
Molecular Pharmacology October 1, 2018, mol.118.113670; DOI: https://doi.org/10.1124/mol.118.113670

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Reduced Activity of GGPPS Mutant is Involved in Bisphosphonates-Induced Atypical Fractures

Michal Lisnyansky, Noa Kapelushnik, Ariel Ben-Bassat, Milit Marom, Anat Loewenstein, Daniel Khananshvili, Moshe Giladi and Yoni Haitin
Molecular Pharmacology October 1, 2018, mol.118.113670; DOI: https://doi.org/10.1124/mol.118.113670
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAAR Molecular Identity in Oligodendrocytes
  • Editing TOP2α Intron-19 5′ SS Circumvents Drug Resistance
  • SerpinA3N and drug induced liver injury
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics